Protecting against Future Shock — Inhalational Anthrax  

Oleh:

Nabel, Gary J.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 361 no. 02 (Jul. 2009), page 191-193 .
Topik: Anthrax

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2009.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In a world filled with pressing unmet medical needs, why would a physician want to protect against a disease that is rarely seen? Part of the answer can be deduced from the events of the fall of 2001. The deliberate release of anthrax spores on unsuspecting U.S. citizens in the wake of September 11 unsettled Americans who were already concerned about the weaponization of smallpox, Ebola and Marburg viruses, and other pathogens. The subsequent arrival of the highly pathogenic avian influenza virus, together with the recent swine influenza epidemic, has further underscored our vulnerability to infectious diseases, both deliberate and naturally emerging. How can we face these emerging biologic threats? In response, a variety of systems have been established to safeguard public health. The Project Bioshield Act of 2004 provided a mechanism to generate stockpiles of therapeutic drugs and vaccines to protect citizens in the event of outbreaks, and a special agency in the Department of Health and Human Services, the Biomedical Advanced Research and Development Authority, was formed to develop countermeasures for biologic threats.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali